Disclosure Of Entity's Operating Segments [Text Block]

Sopharma Trading AD - Filing #6022496

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Depreciation and amortisation expense
29 984 BGN
28 554 BGN
Tax expense (income)
3 313 BGN
1 387 BGN
Profit (loss) before tax
12 393 BGN
9 437 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
9 080 BGN
9 080 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
8 050 BGN
8 050 BGN
Assets
572 554 BGN
582 859 BGN
Liabilities
478 009 BGN
497 959 BGN
Cash flows from (used in) operating activities
18 580 BGN
172 859 BGN
Cash flows from (used in) investing activities
12 149 BGN
14 325 BGN
Cash flows from (used in) financing activities
11 287 BGN
191 752 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.